Insulin resistance syndrome including obesity, hyperglycemia, hyperlipidemia, and hypertension or insulin therapy in our donors might interfere with the insulin signaling pathway, leading to alteration of the INSR function (43). This evidence concerns the gene INSR and obesity disorder.